SCHEMBL626242

SCHEMBL626242

CS(=O)(=O)N1CCC2(CC1)CN(c1nn3c(-c4cnc(N)c(C(F)(F)F)c4)cnc3s1)C2

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 10/20 0.52
MAP3K12 Q12852 1/20 0.43
HASPIN Q8TF76 4/20 0.40
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KCNH2 Q12809 3/20 0.38
FLT3 P36888 2/20 0.38
KIT P10721 1/20 0.38
PIM1 P11309 1/20 0.38
CDK7 P50613 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625702 0.89 PIK3CA (0.50) PIK3CAMAP3K12HASPINKCNH2FLT3
SCHEMBL626243 0.86 MAP3K12 (0.46) PIK3CAMAP3K12USP2ALDH1A1CYP3A4
SCHEMBL626619 0.84 PIK3CA (0.55) PIK3CAMAP3K12HASPINKCNH2
SCHEMBL625458 0.84 PIK3CA (0.51) PIK3CAMAP3K12HASPINKCNH2FLT3
SCHEMBL627019 0.83 PIK3CA (0.47) PIK3CAMAP3K12HASPINKCNH2FLT3
SCHEMBL626262 0.81 PIK3CA (0.54) PIK3CAMAP3K12HASPINKCNH2FLT3
SCHEMBL626160 0.81 PIK3CA (0.50) PIK3CAMAP3K12KCNH2
SCHEMBL626461 0.80 PIK3CA (0.47) PIK3CAHASPINKCNH2FLT3KIT
SCHEMBL624438 0.79 PIK3CA (0.50) PIK3CAHASPINKCNH2FLT3KIT
SCHEMBL624967 0.78 PIK3CA (0.55) PIK3CAMAP3K12HASPINKCNH2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed